Oliver Reinberg analyst KEPLER CHEUVREUX

Currently out of the existing stock ratings of Oliver Reinberg, 1 are a SELL (20%), 2 are a HOLD (40%), 2 are a BUY (40%).

Oliver Reinberg

Work Performance Price Targets & Ratings Chart

Analyst Oliver Reinberg, currently employed at KEPLER CHEUVREUX, has had 16.67% of price targets met with an average potential upside of 9.85%, reached in 120 days on average.

Oliver Reinberg has documented 10 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on QGEN, Qiagen NV at 13-Jul-2021.

Wall Street Analyst Oliver Reinberg

Analyst best performing recommendations are on QGEN (QIAGEN NV).
The best stock recommendation documented was for QGEN (QIAGEN NV) on 11/14/2019. The price target of $40.53 was fulfilled within 239 days with a profit of $6.67 (19.7%), with a performance score of 0.82.

Average potential price target upside

QGEN Qiagen NV FMS Fresenius Medical Care

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 07-Jan-2020

$50

$-0.1 (-0.20%)

$52

4 days ago
(12-Nov-2026)

Buy Since 27-Oct-2026

$53

$2.9 (5.79%)

$55

20 days ago
(27-Oct-2026)

3/9 (33.33%)

$2.83 (5.64%)

154

Buy Since 17-Jun-2024

$52

$1.9 (3.79%)

$55

26 days ago
(21-Oct-2026)

2/6 (33.33%)

$1.78 (3.54%)

114

Buy Since 21-Oct-2026

$52

$1.9 (3.79%)

$43

26 days ago
(21-Oct-2026)

5/9 (55.56%)

$1.78 (3.54%)

253

Hold Since 05-Oct-2026

$55

$4.9 (9.78%)

$35.72

1 months 11 days ago
(05-Oct-2026)

5/6 (83.33%)

$9.35 (20.48%)

534

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Oliver Reinberg?

On 2019
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?